Today the National Coalition for Cancer Survivorship (NCCS) announces the appointment of a group of leaders in the oncology field to serve as Cancer Policy Advisors. The slate of advisors includes leading researchers, oncologists, scholars, payers, and cancer center and survivorship program directors, who will provide guidance to NCCS as it represents cancer patients and survivors on policy issues related to cancer care delivery, payment, and quality improvement.

NCCS is fortunate to have long-standing relationships with leaders in the cancer field who share their expertise and experience. Their guidance enhances our effectiveness as we advocate for policies that help make cancer patients, and the system that cares for them, better.

“The health care system is evolving, which means changes to the cancer care delivery and payment system. The patient voice is essential to these discussions, and NCCS has long been a credible, effective voice for patients and a leader in patient-centered public policy efforts,” said Therese Mulvey, MD, Physician-in-Chief of the Southcoast Centers for Cancer Care. “I am honored to serve as an advisor to NCCS.”

Cancer Policy Advisors 

Stuart M. Butler, PhD, The Heritage Foundation

John V. Cox, DO, Texas Oncology

Scott Gottlieb, MD, American Enterprise Institute

Pamela (P.J.) Haylock, RN, Oncology nurse, advocate, author

Michael Kolodziej, MD, Aetna

Michael Link, MD, Stanford University School of Medicine

Mary McCabe, RN, MN, Memorial Sloan-Kettering Cancer Center

Therese M. Mulvey, MD, FASCO, Southcoast Centers for Cancer Care

Lee Newcomer, MD, UnitedHealthcare

Kevin C. Oeffinger, MD, Memorial Sloan-Kettering Cancer Center

Ann H. Partridge, MD, MPH, Dana-Farber Cancer Institute,

Kavita Patel, MD, The Brookings Institution

Derek Raghavan, MD, PhD, FACP, FASCO, Levine Cancer Institute

Jeffery Scott, MD, Strategic Oncology Consultants

Thomas Smith, MD, Johns Hopkins Medicine

Jennifer S. Temel, MD, Massachusetts General Hospital